Company Filing History:
Years Active: 2010
Title: **Inventor Manlio Palumbo: A Pioneer in DNA-based Aptamers**
Introduction
Manlio Palumbo is an innovative inventor based in Padua, Italy, known for his groundbreaking research in the field of biochemistry. With a focus on developing non-peptidic inhibitors for cathepsin G, his contributions are pivotal to the advancement of treatments for inflammatory occurrences and procoagulant conditions.
Latest Patents
Palumbo holds a significant patent titled "DNA-based aptamers for human cathepsin G." This patent showcases his dedication to identifying inhibitors characterized by high levels of selectivity. The invention consists of linear DNA or polynucleotide sequences with a chain length of at least 60 nucleotides, specifically designed to not undergo efficient base pairing.
Career Highlights
As an influential figure at Gentium S.p.a., Palumbo’s work is instrumental in the field of therapeutic innovations. His research is vital in exploring new avenues for medical treatments, particularly in the realm of inflammation and coagulation disorders.
Collaborations
Palumbo collaborates closely with notable coworkers such as Barbara Gatto and Rodolfo Pescador. Their collective expertise contributes to innovative projects that push the boundaries of current medical research.
Conclusion
Manlio Palumbo’s work exemplifies the spirit of innovation in the scientific community. His patented DNA-based aptamers represent a significant advancement in the development of targeted therapies, showcasing the important interplay between invention and practical application in modern medicine.